Brief: Nanoform, Celanese Expand Collaboration
Sept 5 (Reuters) - Nanoform Finland Oyj NANOFH.HE :
* NANOFORM AND CELANESE EXPAND COLLABORATION INTO LONG-ACTING BIOLOGICS DELIVERY THROUGH
SMALL
IMPLANTS
* PARTIES TO COMBINE NANOFORM'S BIOLOGICS PLATFORM WITH CELANESE VITALDOSE DRUG DELIVERY
PLATFORM
* IN THIS COLLABORATION BOTH PARTIES CARRY THEIR OWN COSTS OF DEVELOPMENT
Source text for Eikon: ID:nWkrW250t
Further company coverage: NANOFH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nanoform Finland Oyj
See all newsFinland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cuts
Brief: Nanoform Q2 EBITDA EUR -3 Million
Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
Finland's Nanoform Q1 revenue rises 45%, EBITDA loss narrows
Brief: Nanoform Finland Targets Cash Burn Below EUR 10 Mln For 2026